Lv2
132 积分 2025-09-17 加入
Analysis of clinical features and related factors of three types of capsule-related complications after phacoemulsification
12天前
已完结
TEMPORARY REMOVAL: Four-Year Outcomes of Faricimab in Diabetic Macular Edema
1个月前
已完结
TEMPORARY REMOVAL: Four-Year Outcomes of Faricimab in Diabetic Macular Edema
1个月前
已关闭
REAL-WORLD DURABILITY OF AFLIBERCEPT 8 MG AND FARICIMAB IN INITIATORS VERSUS SWITCHERS: A Multicenter Retrospective Analysis
1个月前
已完结
Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
1个月前
已完结
Histopathology of silicone oil keratopathy in humans
1个月前
已关闭
Neutrophil-dependent interferonopathy contributes to joint damage in hemophilia
1个月前
已完结
Comparison of Retinal Nonperfusion in Diabetic Macular Edema Treated with Brolucizumab Versus Aflibercept: A KINGFISHER Trial Analysis
1个月前
已完结
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: 96-Week Results from the Randomized Phase 2/3 PHOTON Trial
1个月前
已完结
Resolution of Angiographic Macular Leakage with Faricimab Versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE
1个月前
已完结
皖公网安备34019202002308
